Kestra Advisory Services’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
Kestra Advisory Services's LMAT Position: Q1 2026 in Review
Kestra Advisory Services sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 843 shares — an estimated $68.4K sold.
Kestra Advisory Services first reported a position in LMAT in Q4 2025 and held it in 1 quarter. The position peaked at $68.4K in Q4 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- Kestra Advisory Services reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
- Kestra Advisory Services sold 843 LeMaitre Vascular shares in Q1 2026, an estimated $68.4K.
- Kestra Advisory Services first reported a position in LeMaitre Vascular in Q4 2025 and held it in 1 quarter.
- Kestra Advisory Services's LeMaitre Vascular position peaked at $68.4K in Q4 2025.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.